Kyung Soo Lee Selected Research

Baritosis

1/2006

Pneumoconiosis: comparison of imaging and pathologic findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung Soo Lee Research Topics

Disease

39	Neoplasms (Cancer) 05/2022 - 06/2003
16	Adenocarcinoma of Lung 01/2019 - 05/2011
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 09/2005
11	Lung Diseases (Lung Disease) 01/2021 - 07/2005
10	Neoplasm Metastasis (Metastasis) 06/2019 - 06/2003
9	Bronchiectasis 01/2022 - 04/2005
7	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 10/2002
7	Lung Neoplasms (Lung Cancer) 12/2012 - 11/2004
5	Pneumonia (Pneumonitis) 01/2022 - 10/2018
5	Adenocarcinoma 01/2018 - 04/2012
4	Cysts 02/2014 - 07/2002
3	Dermatomyositis (Dermatopolymyositis) 01/2022 - 10/2002
3	Esophageal Squamous Cell Carcinoma 01/2022 - 11/2004
3	Polymyositis 01/2022 - 10/2002
3	Ankylosing Spondylitis 01/2022 - 10/2002
3	Rheumatoid Arthritis 01/2022 - 10/2002
3	Mixed Connective Tissue Disease (MCTD) 01/2022 - 10/2002
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 10/2002
3	Disease Progression 03/2021 - 02/2016
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 11/2011
3	Idiopathic Pulmonary Fibrosis 01/2021 - 10/2002
3	Pulmonary Tuberculosis 05/2009 - 04/2004
3	Tuberculosis (Tuberculoses) 05/2009 - 09/2006
3	Solitary Pulmonary Nodule 08/2008 - 10/2004
2	Sjogren's Syndrome (Sjogren Syndrome) 01/2022 - 01/2021
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 01/2021
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2021 - 10/2002
2	Vascular Diseases (Vascular Disease) 01/2020 - 10/2002
2	Breast Neoplasms (Breast Cancer) 01/2017 - 10/2015
2	Extensively Drug-Resistant Tuberculosis 11/2015 - 05/2009
2	Sarcoma (Soft Tissue Sarcoma) 02/2014 - 01/2004
2	Bronchiolitis 10/2013 - 04/2005
2	Hemorrhage 07/2012 - 10/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2012 - 06/2003
2	Hamman-Rich Syndrome (Hamman Rich Syndrome) 11/2011 - 03/2006
2	Acquired Immunodeficiency Syndrome (AIDS) 07/2010 - 05/2009
2	Granuloma 09/2008 - 02/2007
2	Lymphatic Metastasis 05/2008 - 01/2008
2	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 10/2005 - 11/2004
2	Infections 07/2005 - 04/2005
1	Hypoxia (Hypoxemia) 03/2022
1	Pulmonary Infarction 03/2022
1	Pulmonary Hypertension 03/2022
1	Pathologic Complete Response 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Human Influenza (Influenza) 01/2020
1	COVID-19 01/2020
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2019
1	Rare Diseases (Rare Disease) 10/2018
1	Pulmonary Alveolar Proteinosis 10/2018
1	Teratoma (Teratoid Tumor) 08/2015
1	Osteomyelitis 06/2015
1	Arthritis (Polyarthritis) 06/2015
1	Paresthesia (Dysesthesia) 01/2015

Drug/Important Bio-Agent (IBA)

17	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2019 - 06/2003
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 10/2005
7	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2012
6	Pharmaceutical PreparationsIBA 01/2021 - 03/2006
6	AcidsIBA 05/2009 - 04/2005
5	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2011
5	Tyrosine Kinase InhibitorsIBA 11/2016 - 07/2011
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	Anaplastic Lymphoma KinaseIBA 06/2018 - 01/2015
3	Fluorine-18IBA 11/2007 - 11/2004
2	Indicators and Reagents (Reagents)IBA 03/2022 - 10/2018
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022 - 01/2021
2	CollagenIBA 01/2020 - 10/2002
2	Contrast MediaIBA 01/2017 - 11/2005
2	IodineIBA 01/2016 - 11/2012
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2015 - 02/2007
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2015 - 02/2007
2	MucinsIBA 03/2013 - 10/2005
2	ferric oxide (iron oxide)IBA 12/2012 - 01/2006
2	Biological ProductsIBA 10/2005 - 04/2003
1	DNA (Deoxyribonucleic Acid)IBA 05/2022
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 03/2022
1	AminesIBA 03/2022
1	ProcalcitoninIBA 03/2021
1	xylometazoline (stas)IBA 12/2018
1	Surface-Active Agents (Surfactants)IBA 10/2018
1	Genetic Markers (Genetic Marker)IBA 06/2018
1	Colloids (Colloid)IBA 01/2018
1	betaglycan (TGFBR3)IBA 01/2018
1	Linezolid (Zyvox)FDA Link 11/2015
1	Amantadine (Aman)FDA LinkGeneric 01/2015

Therapy/Procedure

26	Therapeutics 01/2022 - 04/2004
7	Traction 01/2022 - 09/2012
5	Lymph Node Excision (Lymph Node Dissection) 06/2019 - 06/2003
5	Drug Therapy (Chemotherapy) 08/2015 - 09/2010
3	Aftercare (After-Treatment) 10/2018 - 04/2012
3	Neoadjuvant Therapy 01/2014 - 02/2011
2	Precision Medicine 01/2018 - 07/2012
2	Chemoradiotherapy 01/2015 - 08/2006
2	Thoracotomy 05/2013 - 07/2012
2	Esophagectomy 11/2004 - 06/2003
1	Immunotherapy 03/2019
1	Adjuvant Chemotherapy 06/2018
1	Adjuvant Radiotherapy 10/2015
1	Radiotherapy 10/2015
1	Hip Replacement Arthroplasty (Total Hip Replacement) 06/2015